Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2017 Jul-Aug;39(4):537-538.
doi: 10.4103/0253-7176.211763.

Olanzapine-induced Skin Eruptions

Nishtha Chawla  1 , Saurabh Kumar  1 , Yatan Pal Singh Balhara  1   2   3   4
Affiliations
Case Reports

Olanzapine-induced Skin Eruptions

Nishtha Chawla et al. Indian J Psychol Med. 2017 Jul-Aug.

Abstract

Adverse cutaneous reactions are known to occur with psychotropic medications, which may lead to poor drug compliance. As compared to other group of psychotropics, there is relatively scarce literature on olanzapine-induced skin eruptions. We present a case of a 39-year-old man diagnosed with first episode mania and alcohol dependence syndrome who was started on tablet olanzapine which leads to fixed drug eruptions. Exhaustive investigations were done, all of which came out within normal limits. A diagnosis of fixed drug eruptions was made by the dermatologist. The skin eruptions subsided after stopping olanzapine. It has, thus, been emphasized that clinicians should be aware of the potential cutaneous eruptions associated with olanzapine. Early detection of the same would lead to timely management and hence better compliance with the psychotropic treatment.

Keywords: Antipsychotic agents; drug eruptions; olanzapine.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Figures

Figure 1
Figure 1
(a) Olanzapine-induced skin eruptions. (b) Hyperpigmented marks after resolution of Olanzapine-induced skin eruptions
See this image and copyright information in PMC

References

    1. Christen S, Gueissaz F, Anex R, Zullino DF. Acute generalized exanthematous pustulosis induced by olanzapine. Acta Medica (Hradec Kralove) 2006;49:75–6. - PubMed
    1. Duggal MK, Singh A, Lolis JD, Guzik HJ. Olanzapine-induced vasculitis. Am J Geriatr Pharmacother. 2005;3:21–4. - PubMed
    1. Molina-Ruiz AM, Molina-Ruiz RM, Zulueta T, Barabash R, Requena L. Olanzapine-induced eccrine squamous syringometaplasia. Am J Dermatopathol. 2012;34:434–7. - PubMed
    1. Raz A, Bergman R, Eilam O, Yungerman T, Hayek T. A case report of olanzapine-induced hypersensitivity syndrome. Am J Med Sci. 2001;321:156–8. - PubMed
    1. Chang HY, Ridky TW, Kimball AB, Hughes E, Oro AE. Eruptive xanthomas associated with olanzapine use. Arch Dermatol. 2003;139:1045–8. - PubMed

Publication types